SITARAP-D is a combination diabetes medication with SGLT2 inhibitor and DPP-4 inhibitor for comprehensive blood sugar control with cardiovascular benefits. Dapagliflozin promotes glucose excretion through the urine, while sitagliptin enhances insulin secretion and suppresses glucagon release. This dual mechanism provides effective glycemic control, weight management, and cardiovascular protection, making SITARAP-D an ideal choice for patients with type 2 diabetes who require additional blood sugar control or have cardiovascular risk factors.
SITARAP-D: Dapagliflozin + Sitagliptin for Diabetes Control
Category: Tablets
Packaging: 10x10 Alu Alu
Composition: Dapagliflozin IP 10mg + Sitagliptin Phosphate Monohydrate IP 100mg
Therapeutic Class: Antidiabetic
Strength: 10mg + 100mg per tablet
MRP: ₹2050.00
SCHEDULE H PRESCRIPTION DRUG - WARNING:To be sold by retail on the prescription of a Registered Medical Practitioner only.
Request Info Introduction
Uses & Indications
- Type 2 diabetes management
- Blood glucose control
- Cardiovascular protection
- Weight management in diabetics
- Combination therapy for improved glycemic control
Contraindications
- Type 1 diabetes
- DKA history
- Severe renal disease
Side Effects
The side effects listed below may occur with the use of this medication. However, not all individuals experience these effects.
- Genital infections
- Urinary frequency
- Headache
- Hypoglycemia (when with other agents)
- Pancreatitis (rare)
Precautions
- Monitor blood glucose
- Maintain genital hygiene
- Adequate hydration
Safety Advice & Precautions
- Take regularly as prescribed
- Monitor blood glucose regularly
- Maintain good genital hygiene
- Report signs of urinary tract infections
- Adequate hydration important
- Regular medical follow-ups required
Storage Conditions
Store at temperature not exceeding 25°C. Protect from moisture.
Shelf Life & Expiry
24 months
Frequently Asked Questions
How does SITARAP-D help with Sitagliptin role?
DPP-4 inhibitor for Type 2 diabetes
How does SITARAP-D help with D combination?
Often combined with other agents
Does taking SITARAP-D increase my risk of hypoglycemia (low blood sugar)?
Lower risk compared to insulin
What is the recommended daily dosing schedule for SITARAP-D?
Usually once or twice daily
Medical Disclaimer
This product information is for educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always consult with a healthcare professional before starting any new medication or changing your dosage. Rapid Pharmaceuticals is not responsible for any adverse effects resulting from the misuse of this medication.
